Evaluation of nafamostat mesilate as an alternative anticoagulant during intermittent hemodialysis in healthy Beagle dogs.

Joon-Hyuk ChoiSeok-Yeong ByunAryung NamSei-Myoung HanKyu-Pil LeeKun-Ho SongHwa-Young YounKyoung-Won Seo

Published in: Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001) (2018)

The results of this study in healthy Beagle dogs suggest that NM at 0.25 mg/kg/h may be a valid alternative to UFH for IHD. Further studies are needed in patients at high risk of bleeding.

Keyphrases

atrial fibrillation
photodynamic therapy
peritoneal dialysis
high intensity
end stage renal disease
light emitting